BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
7.51
-0.29 (-3.72%)
Jan 2, 2026, 2:22 PM EST - Market open
BioCryst Pharmaceuticals Analyst Ratings
Total Analysts
12
Consensus Rating
Strong Buy
Price Target
$20.08
Upside
+167.38%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $32 | Strong Buy | Maintains | $30 → $32 | +326.10% | Dec 15, 2025 |
| Citizens | Citizens | Buy Maintains $27 → $25 | Buy | Maintains | $27 → $25 | +232.89% | Nov 5, 2025 |
| Barclays | Barclays | Hold Maintains $11 → $9 | Hold | Maintains | $11 → $9 | +19.84% | Nov 4, 2025 |
| Needham | Needham | Strong Buy Maintains $20 → $18 | Strong Buy | Maintains | $20 → $18 | +139.68% | Nov 4, 2025 |
| TD Cowen | TD Cowen | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +299.47% | Oct 15, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $24 → $26 | Buy | Maintains | $24 → $26 | +246.21% | Oct 15, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $17 → $27 | Buy | Maintains | $17 → $27 | +259.52% | Oct 15, 2025 |
| Needham | Needham | Strong Buy Maintains $17 → $20 | Strong Buy | Maintains | $17 → $20 | +166.31% | Oct 15, 2025 |
| Needham | Needham | Strong Buy Maintains $17 | Strong Buy | Maintains | $17 | +126.36% | Aug 4, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $13 → $15 | Strong Buy | Maintains | $13 → $15 | +99.73% | Jul 1, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $13 | Buy | Reiterates | $13 | +73.10% | Jun 30, 2025 |
| Wedbush | Wedbush | Buy Maintains $16 → $18 | Buy | Maintains | $16 → $18 | +139.68% | Jun 30, 2025 |
| Needham | Needham | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +126.36% | Jun 27, 2025 |
| Needham | Needham | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +126.36% | Jun 25, 2025 |
| Barclays | Barclays | Hold Maintains $8 → $11 | Hold | Maintains | $8 → $11 | +46.47% | May 7, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $11 → $13 | Buy | Reiterates | $11 → $13 | +73.10% | May 6, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.